BSX

Boston Scientific Corporation

Healthcare
47.68 -0.30 -0.63% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 70.87B
EV —
Shares Out 1.49B
Revenue (ttm) 20.61B
Net Income 3.56B
Beta —
P/E 19.86
Forward P/E —
EPS (ttm) $2.39
P/S 3.43
P/B 2.74
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 8.3%
ROE 14.77%
ROIC 9.78%
Gross Margin 69.17%
Oper. Margin 18.4%
Profit Margin 17.29%
Debt/Eq 0.43
LT Debt/Eq 29.82%
Quick Ratio —
Current Ratio 1.90
Book/sh 17.42
Cash/sh 0.98
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -11.27%
SMA50 -19.49%
SMA200 -43.69%
Volume 21,665,427
Avg Volume 18.42M
Rel Volume —
Perf Week -1.30%
Perf Month -14.83%
Perf Quarter -34.68%
Perf Half Y -51.11%
Perf YTD -49.99%
Perf Year -53.63%
Perf 3Y -7.24%
Perf 5Y 13.44%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The company has advanced the practice of less-invasive medicine for more than 45 years by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients' quality of life by providing alternatives to surgery and other medical procedures. The company operates through two reportable segments: MedSurg and Cardiovascular. MedSurg includes endoscopy, urology, and neuromodulation business units that develop and manufacture minimally invasive devices for gastrointestinal, pancreaticobiliary, urological, and neurological conditions. The Cardiovascular segment provides interventional cardiology, vascular therapies, electrophysiology, cardiac rhythm management, watchman, and interventional oncology products. The company's portfolio helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

Name
Boston Scientific Corporation
Industry
Medical Devices
CEO
Michael F. Mahoney · Chairman of the Board of Directors, President and Chief Executive Officer
Employees
59,000 as of 2025-12-31
IPO Date
2020-06-18
Phone
(508) 683-4000
Address
300 Boston Scientific Way, Marlborough, MA 01752-1234
Website
www.bostonscientific.com

Key Executives

Name Title FY Pay
Michael F. Mahoney Chairman of the Board of Directors, President and Chief Executive Officer —

Latest News